Related Experiment Videos
Impaired leukotriene B4 release by neonatal polymorphonuclear leukocytes
D Viggiano1, G Romano, M Caniglia
1Department of Pediatrics, University Federico II, Naples, Italy.
Pediatric Research
|July 1, 1994
Summary
Newborns show altered Leukotriene B4 (LTB4) release from polymorphonuclear leukocytes (PMN). While A23187 stimulated higher LTB4 in neonates, serum-treated zymosan showed lower release, indicating potential PMN dysfunction in infants.
Area of Science:
- Immunology
- Neonatal Research
- Inflammation Biology
Background:
- Leukotriene B4 (LTB4) is a key inflammatory mediator produced by polymorphonuclear leukocytes (PMN).
- Neonatal susceptibility to infections is linked to PMN dysfunction.
- This study investigates LTB4 release in neonatal PMN to identify potential defects.
Purpose of the Study:
- To assess and compare LTB4 production in neonatal versus adult PMN.
- To investigate potential LTB4 release defects in newborn immune cells.
Main Methods:
- Blood samples were collected from 10 healthy neonates and 10 adult controls.
- PMN were isolated and stimulated with calcium ionophore A23187, serum-treated zymosan, or formyl-methionyl-leucyl-phenylalanine.
- LTB4 release kinetics were measured using radioimmunoassay (RIA) over 30 minutes.
Main Results:
- A23187 significantly increased LTB4 release in neonatal PMN compared to adults (p < 0.01).
- Serum-treated zymosan induced significantly lower LTB4 release in neonatal PMN versus adults (p < 0.01).
- Formyl-methionyl-leucyl-phenylalanine stimulation showed variable LTB4 release in both groups.
Conclusions:
- Neonatal PMN exhibit distinct LTB4 release patterns compared to adults.
- These findings suggest potential dysfunctions in neonatal PMN inflammatory responses.
- Further research is warranted to understand the implications for infant immunity.